About 2 results found for searched term "JNJ-26481585" (0.413 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2119 | JNJ-26481585 | HDAC |
| Quisinostat | ||
| JNJ-26481585 (Quisinostat) is a novel second-generation class I HDAC inhibitor. | ||
| M20389 | Quisinostat (JNJ-26481585) 2HCl | HDAC |
| Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM in a cell-free assay, modest potent to HDACs 2, 4, 10, and 11 greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. Phase 2. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
